more aggressive treatment of SYSTOLIC hypertension
The NIH is now urging more aggressive treatment of SYSTOLIC hypertension.
The focus used to be on lowering DIASTOLIC blood pressure...higher systolic BP was considered an inevitable part of aging.
But now we know that systolic blood pressure is a better indicator of cardiovascular risk in middle-aged and older patients.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote